European Pharmaceutical Review

JULY 7, 2023

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. Technological solutions and policy recommendations for government have been identified as a way to help make sectors such as biopharma and Medtech more innovative and increase their value added.

Competition 104

Competition Biopharma Government Manufacturing 104

Fierce Pharma

JANUARY 3, 2024

Morgan Healthcare Conference rolled on in San Francisco, BioNTech, Alnylam and many other companies updated investors on their strategies heading into 2024. As the J.P. | As the J.P.

Biopharma 337

Biopharma Sales Healthcare Healthcare 337

Fierce Pharma

JUNE 11, 2024

Amid a recent biopharma M&A resurgence, one major player plans to stay out of the waters after making multiple recent splashes.

Biopharma 305

Biopharma Healthcare Healthcare 305

Fierce Pharma

FEBRUARY 27, 2024

A seismic shift has occurred in the healthcare landscape. Delivering on these heightened expectations has fueled the urgency to invest in patient engagement and support.

Biopharma 219

Biopharma Patients Healthcare Healthcare 219

Pharmaceutical Technology

JUNE 24, 2022

invoX Pharma has signed a definitive agreement for the acquisition of all issued and outstanding shares of clinical-stage biopharma firm F-star Therapeutics, in a deal valued at nearly $161m or $7.12 invoX Pharma is a fully owned Sino Biopharmaceutical subsidiary. for each share in cash.

Biopharma 64

Biopharma Pharma Pharmacology Healthcare 64

European Pharmaceutical Review

SEPTEMBER 15, 2023

For its 20 th anniversary, more than 180 entries across 12 categories have been narrowed down to determine the finalists the upcoming CPHI Pharma Awards. To recognise the influx of innovation across the pharmaceutical industry, three new categories are included in this year’s awards.

Pharma 119

Pharma Manufacturing Biopharma Pharmaceutical 119

Fierce Pharma

JUNE 11, 2024

braces for a potential government shake-up ahead of its general election next month, the country’s premier biopharma trade organization is throwing down the gauntlet. | political parties to blueprint their plans to unlock the nation’s healthcare industry potential, according to a press release issued Monday. As the U.K.

Biopharma 225

Biopharma Government Healthcare Healthcare 225

PM360

FEBRUARY 1, 2024

Embarking on the journey from product development to market success in the biopharma industry is no small feat. According to a McKinsey report , a startling 40% of biopharma products fail to meet their sales forecasts within the initial two years, prompting a critical reassessment of strategies for product launches.

Biopharma 59

Biopharma Competition Prescription Marketing 59

Fierce Pharma

SEPTEMBER 19, 2023

Artificial intelligence (AI) has enormous potential in healthcare, but all too often, it gets misunderstood. With the right infrastructure, intelligent tools stand to not only process data but also improve clinical decision-making—helping find more patients for biopharma companies, and faster, too.

Biopharma 259

Biopharma Healthcare Healthcare Patients 259

MedCity News

JANUARY 8, 2024

Johnson & Johnson’s acquisition of antibody drug conjugate developer Ambrx Biopharma comes as Novartis and Merck also unveiled M&A deals on the first day of the J.P. Morgan Healthcare conference. In a report, the investment bank said big pharmas are looking for deals involving de-risked assets.

Biopharma 94

Biopharma Pharma Healthcare Healthcare 94

Eversana Intouch

NOVEMBER 9, 2023

Back in 2003, drugs from large pharma companies made up 36% of the late-stage R&D pipeline. These data are astonishing, given the perception that Big Pharma is the main driver of biopharma innovation. Yet, we know small-to-mid-sized pharma launches face a unique set of challenges. Not anymore.

Pharma 105

Pharma Biopharma Competition Marketing 105

Pharmaceutical Commerce

SEPTEMBER 6, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Distribution 52

Distribution Biopharma Leads Healthcare 52

PharmExec

JUNE 21, 2023

Biopharma aims to strengthen field engagement with healthcare professionals.

Biopharma 98

Biopharma Pharma Healthcare Healthcare 98

PM360

AUGUST 9, 2022

Biopharma blockbusters in the last 10 years show a disturbing trend. As a top 10 biopharma company leader shared with us, “Real blockbusters are gone. Innovation Is Expanding, But Healthcare Systems Are Slow to Adapt. On average, they returned 11% less global revenue than previous years’ launches. In oncology, it’s 47% less.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

MedCity News

JULY 31, 2024

Here is a selection of recent executive hires, retirements, promotions and layoffs occurring across the healthcare industry. The post Healthcare Moves: A Monthly Summary of Hires and Layoffs appeared first on MedCity News.

Healthcare 93

Healthcare Healthcare Medicine Biopharma 93

European Pharmaceutical Review

JANUARY 12, 2023

Out of 19 companies honoured with the 2022 Terra Carta Seal, the three pharma companies awarded were: GlaxoSmithKline PLC. ” Biopharma successful in achieving climate-related goals, report finds. The post 2022 Terra Carta Seal: three pharma companies awarded appeared first on European Pharmaceutical Review.

Pharma 105

Pharma Biopharma Manufacturing Government 105

pharmaphorum

DECEMBER 18, 2022

However, most models are based on an old-fashioned and expensive call centre-based approach that fails to meet the needs of patients and healthcare providers (HCPs) as consumers. Yet, the healthcare experience is antiquated. entertainment or consumer apps), before it is production-worthy for mission-critical healthcare applications.

Biopharma 91

Biopharma Patients Prescription Medical 91

Pharma Marketing Network

MARCH 25, 2022

With an estimated 65 million people serving as caregivers, 1 the role is now a factor in an ever-increasing list of healthcare priorities. If caregiving is positioned as an essential service and caregivers are counted among healthcare’s front-line service providers, 4 does it follow caregivers are a viable healthcare vertical?

Pharma 98

Pharma Education Training Transportation 98

PharmExec

JULY 21, 2023

In this latest Harvard Business School Healthcare Alumni Association Q&A, JT Saunders, Chief Diversity Officer at global consulting firm Korn Ferry, discusses diversity in pharma, as well as what mentors and mentees should be considering in the workplace.

Biopharma 98

Biopharma Consulting Pharma Healthcare 98

pharmaphorum

JANUARY 9, 2023

Biopharma and healthcare group Chiesi Farmaceutici S.p.A. is to acquire the 2015-established Amryt Pharma Plc. The post Chiesi expands rare disease portfolio with Amryt Pharma acquisition appeared first on. in an all-cash transaction at $14.50 per American Depositary Share (ADS). on 6 th January.

Pharma 88

Pharma Biopharma Management Medicine 88

Clarivate

MAY 8, 2024

Doubling down on strategic therapeutic areas Pharma once again finds itself having to narrow its sights on partnerships that deliver the next blockbuster and enable differentiation from the competition—all while navigating increasing regulatory scrutiny and shifting patient and payer expectations.

Pharma 59

Pharma Biopharma Prospecting Competition 59

pharmaphorum

NOVEMBER 28, 2022

Amidst all this, Adelphi Group’s CEO Stuart Cooper found a moment to sit with pharmaphorum web editor Nicole Raleigh and discuss just how exciting it was to bring to vibrant and discursive life the ethos of Anthropy – a united vision for British business, including pharma, and the future of this nation overall.

Pharma 96

Pharma Biopharma Recruitment Management 96

Clarivate

DECEMBER 14, 2021

As the COVID-19 pandemic continues to evolve, we are seeing substantial shifts in the way patients access healthcare and how providers deliver care. More patients are using both pharma and third-party online info sources. Meanwhile, 37% of patients say they spend a lot more time researching health information because of the pandemic.

Pharma 52

Pharma Healthcare Healthcare Physicians 52

Clarivate

OCTOBER 31, 2023

These years witnessed significant troughs in pharma financing, a drop in the capital markets, and an IPO window that remained firmly shut. Big pharma is still keen to access good technology, science, and assets, in many cases to plug a patent-expiry-shaped hole in their coffers. In short, the biotech bubble had burst. Pfizer’s $11.6

Pharma 52

Pharma Biopharma Marketing Healthcare 52

Clarivate

MAY 31, 2023

A glance at the 2022 top selling drugs for the biggest pharma companies reveals how dependent many large pharmas are on a small basket of products – most acquired through partnerships or acquisitions – that are nearing loss of exclusivity. Pharma is placing bigger bets on a smaller number of therapeutics and technology platforms.

Pharma 52

Pharma Biopharma Medicine Healthcare 52

PM360

JUNE 24, 2024

But the role of AI in healthcare will go beyond this. healthcare, with its 17% share of GDP, is “the most disruptable industry in the world,” and “the first big carcass that AI is going to start to feed on.” Efficiencies with AI As for healthcare marketers, there are a number of ways AI is starting to optimize our workflows.

Healthcare 52

Healthcare Healthcare Patients Side effects 52

Pharmaceutical Commerce

JUNE 21, 2023

Biopharma aims to strengthen field engagement with healthcare professionals.

Biopharma 52

Biopharma Pharma Healthcare Healthcare 52

Pharma Marketing Network

MARCH 30, 2023

Mary brings to the HBA 30 years of experience leading the strategic integration of corporate branding, marketing, health equity, inclusion, and digital innovation for biopharma, healthcare, and media companies. Morgan Healthcare Conference. For more information, visit HBAnet.org.

Healthcare 52

Healthcare Healthcare Biopharma Leads 52

pharmaphorum

OCTOBER 11, 2022

The Reuters Pharma event 2022 began as a bustling industry affair yesterday, based out of the Nice Acropolis convention centre on France’s balmy south coast. The onus, he said, was on pharma to listen now. Patient engagement – what history teaches us about pharma’s future evolution. Maximising potential, inspiring in pharma.

Pharma 86

Pharma Patients Medicine Healthcare 86

MedCity News

AUGUST 27, 2023

We can apply this approach in pharma by enhancing our patient journey maps and go beyond focusing on the key clinical engagement touch points (e.g., doctor visits, prescription pickups) and enriching our insights with the micro-moments surrounding these obvious events.

Healthcare 77

Healthcare Healthcare Prescription Doctors 77

PM360

APRIL 22, 2024

The Unique Challenges of Patient/Pharma Interaction Patient engagement has become a critical component of medical marketing. With healthcare professionals becoming less accessible to biopharma reps, the emphasis has shifted toward patient empowerment.

Patients 52

Patients Biopharma Ethics Marketing 52

PharmExec

DECEMBER 8, 2022

Emerging biopharma companies are critical to the vibrancy of the healthcare landscape, but their long road of drug development fails to translate to successful market launch more often than it does for large pharma. What can be done to improve those odds?

Biopharma 52

Biopharma Pharma Healthcare Healthcare 52

Clarivate

APRIL 24, 2023

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. Payers are responding by creating, acquiring or fortifying provider networks and healthcare clinics of their own.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

PM360

SEPTEMBER 30, 2024

Sustainable Tech’s Positive Effect on Pharma Funding Recent innovations, including rapid advancements in AI-powered technologies and GLP-1s, have significantly impacted the investment climate and consolidated funding to a smaller number of organizations in the last eight months.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Competition 52

Pharma Marketing Network

JANUARY 12, 2023

FAIRFIELD, NJ (12 January, 2023) – The Healthcare Businesswomen’s Association (HBA) announces the 2023 Woman of the Year, Honorable Mentor, and STAR. The HBA Woman of the Year award honors a female senior executive whose accomplishments have resulted in significant contributions to the healthcare industry. Jag Dosanjh, President, U.S.

Healthcare 52

Healthcare Healthcare Networking Manufacturing 52

MedCity News

JUNE 16, 2023

Numerous clinical, regulatory and financial factors are behind this digital shift in pharma. UCHealth providers are also notified of these potential changes and can intervene directly if warranted, driving the next level of tech-enabled personalized healthcare.

Pharma 104

Pharma Food and Drug Administration Recruitment Patients 104

European Pharmaceutical Review

SEPTEMBER 12, 2023

As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy. Early adopters started putting these strategies together around 20 years ago.

Consulting 128

Consulting Biopharma Manufacturing Pharmaceutical 128